Synaptogenix regains compliance with Nasdaq listing rules
PremiumThe FlySynaptogenix regains compliance with Nasdaq listing rules
7M ago
Synaptogenix increases stake in psilocybin drug discovery company
Premium
The Fly
Synaptogenix increases stake in psilocybin drug discovery company
7M ago
Synaptogenix Inc trading halted, news pending
Premium
The Fly
Synaptogenix Inc trading halted, news pending
7M ago
Synaptogenix announces agreement with Cleveland Clinic for Bryostatin-1 trial
PremiumThe FlySynaptogenix announces agreement with Cleveland Clinic for Bryostatin-1 trial
1y ago
Synaptogenix’s Bryostatin-1 in Alzheimer’s shows positive Phase 2 results
Premium
The Fly
Synaptogenix’s Bryostatin-1 in Alzheimer’s shows positive Phase 2 results
1y ago
Maxim downgrades Synaptogenix on ‘unclear’ path forward
Premium
The Fly
Maxim downgrades Synaptogenix on ‘unclear’ path forward
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100